0001493152-26-018603
SEC filingSBC Medical Group Holdings entered into an underwriting agreement for the sale of 3,100,000 shares of common stock by CEO Dr. Yoshiyuki Aikawa, which closed on April 21, 2026, with the Company receiving no proceeds.
The underwriting agreement facilitates a secondary offering by Dr. Yoshiyuki Aikawa, the Company's CEO and Chairman, allowing him to sell 3,100,000 shares at $3.0225 each through Maxim Group LLC and other underwriters. This represents liquidity for the executive without direct financial impact to the Company, as it sold no shares and received no proceeds. The 45-day over-allotment option provides underwriters flexibility to stabilize the offering. The transaction utilized an existing S-3 shelf registration filed December 29, 2025, enabling efficient execution. Closing occurred promptly on April 21, 2026, with settlement through DTC, indicating standard market practice.